515 filings
Page 7 of 26
8-K
ZYME
Zymeworks BC Inc
9 Dec 21
Zymeworks Announces Expansion of Zanidatamab Pivotal Trial in Asia in Collaboration with BeiGene and Associated Milestone Payment
4:16pm
8-K
ZYME
Zymeworks BC Inc
9 Dec 21
Zanidatamab Data Presented at the San Antonio Breast Cancer Symposium
12:00am
8-K
ZYME
Zymeworks BC Inc
1 Dec 21
Zymeworks Announces Second Janssen Bispecific Antibody to Begin Clinical Development Utilizing Azymetric™ and EFECT™ Therapeutic Platforms
4:16pm
8-K
ZYME
Zymeworks BC Inc
19 Nov 21
Zymeworks Announces Abstract for Zanidatamab in Late-Line HER2-Positive
4:33pm
4
Neil Josephson
12 Nov 21
Zymeworks / Neil Josephson ownership change
9:00pm
8-K
ZYME
Zymeworks BC Inc
9 Nov 21
Zymeworks Launches Global Phase 3 Zanidatamab Trial in First-Line
5:05pm
8-K
ZYME
Zymeworks BC Inc
8 Nov 21
Zymeworks to Present at Upcoming Investor Conferences
5:01pm
8-K
ZYME
Zymeworks BC Inc
3 Nov 21
Zymeworks Reports 2021 Third Quarter Financial Results
4:19pm
10-Q
2021 Q3
ZYME
Zymeworks BC Inc
Quarterly report
3 Nov 21
4:12pm
8-K
ZYME
Zymeworks BC Inc
26 Oct 21
Zymeworks Announces Webcast to Present HERIZON-GEA-01 Pivotal Trial Design and Zanidatamab Commercial Strategy in Gastrointestinal Cancers
4:16pm
8-K
ZYME
Zymeworks BC Inc
5 Oct 21
Regulation FD Disclosure
4:06pm
8-K
ZYME
Zymeworks BC Inc
1 Oct 21
Entry into a Material Definitive Agreement
5:25pm
424B5
ZYME
Zymeworks BC Inc
1 Oct 21
Prospectus supplement for primary offering
5:10pm
S-3ASR
ZYME
Zymeworks BC Inc
1 Oct 21
Automatic shelf registration
4:45pm
8-K
ZYME
Zymeworks BC Inc
16 Sep 21
Regulation FD Disclosure
4:05pm
8-K
ZYME
Zymeworks BC Inc
13 Sep 21
Regulation FD Disclosure
4:06pm
4
Polverino Anthony J.
2 Sep 21
Zymeworks / Anthony J. Polverino ownership change
8:00pm
8-K
ZYME
Zymeworks BC Inc
4 Aug 21
Zymeworks Reports 2021 Second Quarter Financial Results
4:20pm
10-Q
2021 Q2
ZYME
Zymeworks BC Inc
Quarterly report
4 Aug 21
4:18pm
8-K
ZYME
Zymeworks BC Inc
3 Aug 21
Regulation FD Disclosure
4:06pm